Income on Steroids: How to Earn $10K per Year in Tax-Free Income With Your $100K TFSA

NorthWest Health Prop Real Est Inv Trust (TSX:NWH.UN) and one other investment could make your TFSA filthy rich with distributions.

| More on:

If you’re one of the investors who’ve maxed out their TFSAs every single year and used the proceeds to invest in high-quality dividend-paying stocks, then you’re probably closing in on that $100,000 TFSA milestone. And if you’re not quite there yet, you’ll get there in due time, as the power of long-term tax-free compounding is fairly unfathomable, even if you stick with boring blue chips.

So, if you’re ready to turn your TFSA into a generator of five-figure tax-free income, you may want to consider investing in the two securities I’ll mention in this piece. Both investments have sustainable payouts and are not in a dire situation like most other “artificially high-yielding” securities.

NorthWest Healthcare Properties (TSX:NWH.UN)

With shares down over 24% from 2013 highs, NorthWest is what you’d call an “artificially high yielder,” as the 7.7% yield was probably never intended by management prior to the multi-year plunge that happened around six years ago.

While NorthWest has suffered a big bump in the road, the global healthcare real estate operator has shown that it’s capable of superior net operating income (NOI) growth in addition to ever-strengthening of occupancy rates.

Fellow Fool contributor Karen Thomas noted that healthcare properties have more stable occupancies and longer-term leases than most other types of tenants. Over the next decade, as the Baby Boomer generation continues to age, we’ll undoubtedly see a rise in hospital visits, and as NorthWest scales up, investors can expect above-average distribution growth and capital gains that are comparable to that of a stock.

Inovalis REIT (TSX:INO.UN)

I’ve saved the best for last. Inovalis REIT is my favourite high-yielding security on the entire TSX, and not just because the trust sports a sustainable 8.3% yield.

As a hidden gem, Inovalis is one of the few extremely high yielders that has the potential to offer investors a respectable amount of growth over the years. You see, REITs typically raise their distributions less frequently because payout requirements tend to stunt their growth relative to stocks.

Inovalis, I believe, is a rare exception because of its small size, which allows the trust to operate with more agility as growth opportunities present themselves. The $234 million market cap may scare some conservative income investors, but what they fail to understand is that small-cap REITs are nowhere near as risky as small-cap stocks of the same size.

While Inovalis is undoubtedly on the cusp of a huge growth spurt, it’s going to be less risky when you consider the distribution requirements that Inovalis is subject to, management’s impressive operating track record, and the historically low vacancy rates across Inovalis’s portfolio of European properties.

At the time of writing, the security is off less than 6% from its high. As far-fetched as this may sound, Inovalis may stand to reward you with decent capital gains to go with its already generous 8.3% distribution yield that will likely swell further as growth initiatives allow room for further distribution raises.

Foolish takeaway

These two mega-yielders may seem too good to be true, but they’re not. They’re long-term winners that will not only be able to support such large payouts over time, but they’ll be able to grow it at a rate that most would put most other larger REITs to shame.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned. NorthWest Healthcare is a recommendation of Stock Advisor Canada. Inovalis is a recommendation of Dividend Investor Canada.

More on Dividend Stocks

exchange traded funds
Dividend Stocks

1 Top High-Yield Dividend ETF to Buy to Generate Passive Income

An ETF designed as a long-term foundational holding pays generous monthly dividends.

Read more »

Canadian Dollars bills
Dividend Stocks

Invest $10,000 in This Dividend Stock for $2,430.12 in Passive Income

This dividend stock has proven time and again it's a safe, reliable stock that still has the power to explode…

Read more »

A worker drinks out of a mug in an office.
Dividend Stocks

3 Canadian Dividend Stocks to Consider Adding to Your TFSA in 2025

If you're looking for long-term, undervalued dividend stocks to pick up in your TFSA, consider these first.

Read more »

Canadian dollars are printed
Dividend Stocks

Build a Cash-Gushing Passive-Income Portfolio With Just $25,000

An investment of $25,000 in these high-yield Canadian dividend stocks can help you earn $1,955 in tax-free passive income.

Read more »

dividends grow over time
Dividend Stocks

These Are the Top 4 Undervalued Stocks to Buy Right Now

These four undervalued stocks offer a change to get in on great value long term, with promising futures ahead.

Read more »

stock research, analyze data
Dividend Stocks

Where Will Canadian Tire Stock Be in 5 Years?

With Canadian Tire stock still trading roughly 20% off its all-time high, is it one of the best investments you…

Read more »

a man relaxes with his feet on a pile of books
Dividend Stocks

1 Superb Canadian Dividend Stock Down 17% to Buy in Bulk

This dividend stock is a standout option.

Read more »

The sun sets behind a power source
Dividend Stocks

Should You Buy Fortis While it’s Below $60?

Fortis is off the 12-month high. Is it time to buy?

Read more »